Laura Lee Sandler, Chief Operating Officer, on July 01, 2026, sold 5,000 shares in Oruka Therapeutics (ORKA) for $472,079. Following the Form 4 filing with the SEC, Sandler has control over a total of 236,384 common shares of the company, with 236,384 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/907654/000090765426000069/xslF345X05/form4.xml